Showing results (231-240 of 549) with videos related to

Sort By:
Pageof 55
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Anesthesia for diagnostic and therapeutic procedures in pediatric outpatientsL Ferrari, S Barst, M Pratila, et al.
Bone|December 3, 2014
Periostin expression contributes to cortical bone loss during unloadingMaude Gerbaix, Laurence Vico, Serge L Ferrari, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|March 26, 2002
Freshwater pollution biomarker: response of brain acetylcholinesterase activity in two fish speciesF R de la Torre, L Ferrari, A Salibián
Leukemia & Lymphoma|January 1, 1995
CD34+/CD33+ blast cells: correlation with FAB subtypesG M Rigolin, F Lanza, L Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) GroupM Di Bartolomeo, E Bajetta, A M Bochicchio, et al.
British Journal of Cancer|May 1, 1995
Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical OncologyR Buzzoni, L Biganzoli, E Bajetta, et al.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experienceG Bonadonna, A Santoro, A M Gianni, et al.
Cancer|November 15, 1996
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinomaE Bajetta, M Di Bartolomeo, L Somma, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumorsN Zilembo, R Buzzoni, E Bajetta, et al.
Pageof 55